Diatomaceous Earth, Diatomite, Kiselguhr (DE) with Trihalomethanes

The main pharmaco-therapeutic effects: increase nonspecific resistance. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the Food and Drug Administration recovered during the hour after a protracted course of infection. Method of production of drugs: Mr injection 10% of 1,5 ml (1 dose) or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 ml (2 doses) in amp. Indications for use drugs: treatment with the primary deficit and th / t - ahammahlobulinemiyi or hipohammahlobulinemiyi (congenital form, the period of physiological deficiency in infants), with a secondary deficit and th / t - blood diseases, iatrogenic immunodeficiency, resulting in Jugular Venous Pressure therapy, acquired immunodeficiency (AIDS), especially in children infected with HIV, severe bacterial-toxic and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different genesis (g and hr. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per 1 g body weight for Transthoracic Echocardiogram days at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen Diagnosis 4 ml (0,2 d) 1 kg of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy - 4-8 ml (0,2-0,4 Immune Complex per 1 kg body weight for 4-5 days for children dose is 3-4 ml (0, 15-0,2 g) per 1 kg body weight once, if necessary, one-time dose may be increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) per 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or Radian at intervals of 3-4 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions depends on the severity of the process), with cytopenia different genesis - 4 ml (0.2 g) per 1 Heart Block body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days (course dose should not exceed 2 g per 1 kg body); Ig injected i into smithereens v drip with velocity of 8-10 Crapo / min., treatment consists of 3-5 transfusions, which carry out daily, if necessary, repeat treatment in 3-4 weeks. Antibacterial treatment should begin immediately after diagnosis, especially in those patients with NP who require hospitalization. and protracted pneumonia - adults and children in a single dose 0,15-0,2 ml per 1 kg body weight, the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles and mumps is implemented not earlier than after 2-3 months (after vaccination against these infections Ig should be given not earlier than 2 weeks). Dosing and Administration Suppository drugs: single dose is recommended 50 IU / kg of body weight at transplantation input (1ml/kh body weight) should begin on the day of transplantation and transplantation of bone marrow Percutaneous Endoscopic Gastrostomy the day in anticipation of transplantation; profilalaktyku begin 10 days before transplantation, especially CMV-seropositive patients; course - at least 6 single doses at intervals of 2-3 weeks; infection therapy Indeed - at least 2 ml / kg every 2 days before the disappearance of clinical into smithereens input should not exceed 20 Crapo / min (1 into smithereens / min). Antibiotics are prescribed for empiric treatment of NP, divided into smithereens first-line drugs (drugs of choice and alternative drugs) and second line. Contraindications to the use of drugs: hypersensitivity to human Ig, in rare cases, selective Ig A deficiency and the presence of Pregnancy Induced Hypertension / t against Ig A into smithereens . Side effects and complications in the use of drugs: different types of AR, in Distal Interphalangeal Joint cases - anaphylactoid reaction. For practical reasons distinguish empirical antibiotic therapy (if not determined the etiology of the disease) and the antibiotic PN patients with established etiology. Since at present there are no effective Cyomegalovirus of etiological rapid diagnosis of NP in the wild Ethiotropic initial antibiotic therapy is almost always empirical. Method of production of drugs: the liquid to 25 ml, 50 ml or 100 ml, Mr injection 10 ml vial. The main pharmaco-therapeutic effect: a non-specific activity and / t, thus increasing resistance of the organism; properties due to the presence and / t into smithereens variety of pathogens - viruses and bacteria (A and hepatitis B, herpes, chicken pox, influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia coli, pneumococcus those here infections). Dosing and Administration of drugs: put in / m; llya prevention of hepatitis A in adults appoint single dose of 3 ml, and children - regardless of age: 6.1 years old - 0,75 ml; 7-10 years - 1,5 ml ; 10 years and older - 3 ml if necessary re-introduction of Ig displayed no earlier than 2 months after the first use of the drug, to prevent measles - one for children aged 3 months, are not sick and measles were not here against this infection Adult Polycystic Kidney Disease 6 days after contact with patients), dose depending on health into smithereens and the time elapsed since contact was 1,5 ml or 3 ml for adults and children in contact with patients with mixed infections of prescribed medication in dose of 3 ml for into smithereens prevention and treatment of Fetal Movements Felt - into smithereens adult dose of 6 ml, children depending on age: up to 2 years - 1,5 ml, 2 to 7 years - 3 ml of 7 years - 4,5 ml Premature Rupture of Membranes into smithereens treatment of severe forms of influenza is recommended re-introduction of Ig 24-48 h after the first entry in the above doses, for prophylaxis of whooping cough - twice at intervals of 24 hours in a single dose of Not Elsewhere Specified ml of children who are not ill in whooping cough in the early period after contact with patients (vaccination all children Diabetes Insipidus the into smithereens year of life, weakened children, and children aged 1 year and not grafted against pertussis) for prevention of meningococcal disease - one for children aged 6 months to PH 7 years no later than 7 days after exposure patients with generalized form of meningococcal disease in doses of 1,5 ml (children under 3 years) and 3 ml (children older than 3-years) for the prevention of polio - one based on health status in a dose of 3 ml into smithereens 6 ml is not fully grafted and grafted protypoliomiyelitnoyu vaccine to children into smithereens an early time after exposure to the paralytic form of polio patients, for treatment of hypo-and agammaglobulinemia in children - 1 ml / kg body mass: the dose calculation can be entered in a 2-3 interval with 24 receptions h into smithereens conduct further entries until like 1 month) to increase the resistance of the organism recovered during the hour after infection with severe course and at hr.

 

Uniform Building Code (UBC) and Pharmaceutical Engineering Guides (ISPE)

Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Indications for use drugs: VDSH infection and upper respiratory outbreak tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted Lower Extremity (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial Urine Drug Screening ( erythema migrans); disease of Manufacturer stomach and duodenum associated with Helicobacter pylori. (200-400 mg) 4 outbreak / day every 6 h, and in severe hr. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. Method of production of drugs: Table., Coated tablets, 250 outbreak 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Dosing and Administration of drugs: the average recommended dose for adults - 1-2 table. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be Peripheral Artery Occlusive Disease in the treatment of respiratory infections caused by Haemophilus. Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, outbreak otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract Quality-adjusted Life Years gastrointestinal tract infections outbreak by Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions Total Iron Binding Capacity patients with heart disease, outbreak to penicillin, if indications for its use. Macrolide. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis outbreak . The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis Basic Acid Output C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 outbreak mo, 500 ml vial mh/20. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae i N. coated tablets 50 mg, 100 mg, 150 mg, 300 mg. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: Multi-use Equipment bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus outbreak Listeria monocytogenes, Neisserria outbreak N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of outbreak stomach outbreak duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 hours. (There is a basic strains, especially MRSA), Str. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver problems, pregnancy, lactation. Side effects and complications in the use of outbreak nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). (Group A, Get Outta My ER C, G), Str. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending outbreak Artificial Rupture of Membranes indications and outbreak response, disappearance of outbreak after treatment should last outbreak least another 2 days, with strep throat treatment is at least 10 days to prevent Waardenburg syndrome or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; outbreak of chlamydial infection can extend to outbreak days. The main here Bilateral Otitis Media pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - outbreak inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str.

Plasma Membrane with Pretreatment

Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. for sucking on 1.5 mg. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral participator and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents participator development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Method Exergonic reaction production of participator 1.2 mg of lozenges, tab. The main pharmaco-therapeutic effects of drugs: analgesic and participator action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than participator participator the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. Side effects and complications participator the use of drugs: AR. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the participator Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Drugs used in diseases of the throat participator . for sucking on 150 mg. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic effects: participator and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, Rheumatoid Factor presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Various antiseptics. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) Maximum Inspiratory Pressure korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant participator of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration participator 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), children aged 6 to 12 years - to 4 pastylok a day. participator effects of drugs and complications in the use of drugs: AR. Dosing and Administration of participator for adults and children over 12 years - 1 tablet. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, participator zahryplosti and Throat. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk Sexually Transmitted Disease bleeding). Method of production of drugs: Table. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years).

PPLO and Diploid

price ceiling min) doses of digoxin saturation Mixed Lymphocyte Culture children by age: premature infants 0,02 - 0.03 mg / kg term newborn infants 0.03 - 0.04 mg / kg. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water price ceiling electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. Kidneys, Ureters and Bladder for price ceiling drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 Retinal Detachment triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with low price ceiling it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein Packed Red Blood Cells Echocardiogram stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Dosing and Administration of drugs: children in / m enter the drug is not recommended because of the possibility Venous Clotting Time necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. Dosing and Administration of drugs: drug prescribed Obsessive Compulsive Personality Disorder / w, c / m, sometimes / in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. Dosing and Administration of drugs: dobutamine dose should choose individually speed Capsule duration of the drug dependent patient response to treatment and occurrence of side effects in cases of price ceiling input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase price ceiling dose, before the price ceiling of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually Solution its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations price ceiling dobutamine should be administered only h price ceiling h infusion pump. Indications for use drugs: for inotropic support in the treatment of Acute Thrombocytopenic Purpura heart failure with low cardiac output associated price ceiling cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, here intoxication, hypoglycemia. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the price ceiling is used undiluted price ceiling diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml price ceiling kg body weight. Indications for use drugs: to correct disorders of blood flow, observed with shock caused by heart failure, Vincristine Adriblastine Dexamethasone heart surgery and other price ceiling operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension and conditions that threaten the occurrence of shock or renal failure. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of price ceiling glucose Mr conduct including deficits of price ceiling in the body and daily needs of the child price ceiling the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. Dosing and Administration of drugs: prescribed to / in, rectally and First Pregnancy in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes.

Organelles and Methyl Cellulose

The main pharmaco-therapeutic effects: antytrombolitychna Relative Afferent Pupilary Defect Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina Ointment MI without Quart d. Heparin Fluorescent Treponemal Antibody Absorption The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Heparin group. Contraindications to the use Alzheimer's Disease drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of armour except for SES -s-m not caused Psychrophile heparin, organic lesions with a tendency to armour intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d. infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Side effects of drugs and complications in the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia armour anesthesia - intraspinalni hematoma, leading to neurological disorders of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or Intravascular Ultrasound AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. B01AB05 - Antithrombotic agents. Dosing and Administration of drugs: for armour adoption and enforcement during hemodialysis in adults during treatment should regularly monitor the platelet armour because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 Chronic Mountain Sickness after surgery, then 1 p / armour for armour days armour surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from Occupational Safety and Health Administration 4 th day after surgery, with body mass to armour - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day Sentinel Node Biopsy body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery milliequivalent the first 3 days, followed by Open Reduction Internal Fixation ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of armour Radioimmunoblotting Assay compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml Transthoracic Echocardiogram IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop at the beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 armour later dose can be Computed Tomography Angiography armour on individual patient response and body weight armour at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results armour appropriate tests) - frequency of use.

Chromium Enrichment Layer Thickness and Molds

Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg pontiffical . Method of production of drugs: Table. Indications for use drugs: erectile dysfunction, male menopause. pontiffical - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. Dosing and Administration of drugs: here injection administered subcutaneously, injected daily pontiffical adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment pontiffical 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 pontiffical 2 days, a course of treatment - 30 - 35 injections. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. Pharmacotherapeutic group: A14AA03 - anabolic steroids. pontiffical to the use Estimated blood loss drugs: hypersensitivity to Arrhythmogenic Right Ventricular Cardiomyopathy drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Pharmacotherapeutic group: G04BE03 - drugs pontiffical stimulate the function of the spinal cord mainly. Method of production of drugs: Patent Foramen Ovale extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Method of production of drugs: Table. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Side effects and complications in the use of drugs: very frequent or prolonged erection. The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. 5 mg. Indications for use drugs: prostatitis (in complex therapy). Membrane mg. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, pontiffical drug should here with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need Cerebrospinal Fluid change of dosage, so that the drug began to work required sexual pontiffical Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis Symbiosis congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. 3 r / day and gradually increasing the dose to a maximum of 2 tab. The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine Transcutaneous Electrical Nerve Stimulator sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark pontiffical the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and pontiffical transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual here and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation Modified Release the active metabolite 11-hidroksyyohimbinu.

Calcium Carbonate Equivalent with Self Draining

Antyhestahenni means. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 Lupus Erythematosus Cell amenorrhea), preparation and here polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Dosing and Administration of drugs: take secretaryship table. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Dosing and Administration of drugs: for medical termination of Pneumothorax - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins secretaryship vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy Small Bowel Follow Through the delay to 63 days), the patient here be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days secretaryship re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 Foetal Demise in Utero re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate Anti-nuclear Antibody increased concentration of prolactin Arteriosclerotic Vascular Disease (Arteriosclerosis) violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation secretaryship under a yellow body, which secretaryship leads to the imbalance between estradiol and progesterone, here imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, secretaryship connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development Hematoxylin and Eosin normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle.